Dr. Rajesh Ponugupati. EFFICACY AND SAFETY OF DUAL INTERLEUKIN-17A AND INTERLEUKIN-17F INHIBITION WITH BIMEKIZUMAB IN ACTIVE PSORIATIC ARTHRITIS: RESULTS FROM A PHASE 3 RANDOMISED CONTROLLED TRIAL. J Popl Ther Clin Pharmacol [Internet]. 2016 May 25 [cited 2026 Sep. 17];23(2):237-46. Available from: https://jptcp.com/index.php/jptcp/article/view/13050